antibodi
initi
exposur
allergen
ige
bind
mast
cell
basophil
set
stage
allerg
respons
reexposur
allergen
crosslink
ige
cell
surfac
caus
releas
host
inflammatori
mediat
earli
respons
mediat
includ
granul
mediat
eg
histamin
tryptas
lipid
mediat
eg
leukotrien
prostaglandin
cytokin
tumor
necrosi
factoralpha
tnfa
interleukin
chemokin
produc
minut
hour
later
fig
type
allergen
degre
length
exposur
atop
tendenc
individu
determin
manifest
symptom
sourc
allergen
includ
environ
eg
tree
grass
weed
pollen
dust
mold
food
drug
sting
insect
aeroallergen
subdivid
season
aeroallergen
like
tree
grass
weed
pollen
nonseason
aeroallergen
like
mold
dust
concentr
pollen
atmospher
correl
allerg
manifest
report
dissemin
multipl
center
intern
unit
state
canada
use
resourc
nation
allergi
bureau
provid
pollen
mold
count
approxim
count
station
wwwaaaaiorgnab
physic
manifest
allergi
often
debilit
lung
may
bronchoconstrict
asthma
nose
rhiniti
skin
urticaria
eye
conjunct
system
manifest
allergi
character
anaphylaxi
may
life
threaten
requir
immedi
medic
attent
anaphylaxi
occur
conjunct
exercis
term
exerciseinduc
anaphylaxi
report
certain
individu
addit
inflammatori
respons
allerg
diseas
manifest
associ
fatigu
depress
decrement
cognit
fact
epidemiolog
evid
suggest
season
even
extrem
behavior
manifest
suicid
may
associ
allergi
exposur
season
allergen
specif
tree
pollen
addit
clinic
manifest
allerg
disord
vivo
laboratorybas
test
allergen
sensit
use
strengthen
diagnosi
allerg
diseas
skinprick
intraderm
test
provid
rapid
function
measur
igemedi
hypersensit
skin
result
wheal
flare
respons
occur
within
minut
allergen
contact
situat
decreas
skin
respons
treatment
antihistamin
increas
skin
sensit
dermatograph
logist
constrain
athlet
may
opt
radioallergosorb
test
rast
detect
specif
ige
antibodi
serum
compar
sensit
specif
skinprick
test
athlet
particularli
vulner
effect
environ
mani
athlet
activitieswheth
leisur
train
competitionoccur
outdoor
athlet
train
compet
often
long
durat
time
make
intim
contact
outdoor
element
compris
host
topograph
season
climat
compon
exposur
variou
element
magnifi
increas
ventil
lmin
exercis
intensifi
contact
respiratori
system
environ
inhal
poor
qualiti
cold
air
often
affect
train
yearround
temper
climat
winter
month
cold
air
inhal
exercis
exacerb
exerciseinduc
asthma
peopl
asthma
track
field
athlet
extens
exposur
variou
season
pollen
allergen
spring
tree
summer
grass
earli
fall
ragwe
suscept
athlet
may
develop
conjunctiv
inflamm
rhiniti
bronchial
inflamm
consequ
environment
condit
base
databas
aeroallergen
record
indepth
studi
report
predict
aeroallergen
count
would
observ
associ
olymp
game
athen
greec
studi
predict
peak
pollen
concentr
would
observ
train
march
may
high
level
goosefoot
mugwort
alternaria
cladisporum
spore
would
observ
august
septemb
olymp
game
thu
highlight
need
prepar
test
therapi
earlier
survey
allerg
diseas
elit
athlet
report
australian
olymp
team
allerg
disord
base
clinic
evalu
includ
skin
test
rast
australian
olymp
athlet
studi
sydney
olymp
took
place
period
high
tree
pollen
grain
per
cmm
high
preval
perenni
season
allerg
diseas
report
within
group
report
histori
allerg
rhinoconjunct
symptomat
posit
skin
test
potenti
allergen
diagnos
season
allerg
rhinoconjunct
base
histori
skin
test
suffer
asthma
olymp
athen
greec
inform
regard
circul
aeroallergen
neighbor
citi
publish
attempt
minim
allergi
symptom
help
athlet
achiev
peak
perform
understand
incid
advers
respons
season
allergen
common
amongst
athlet
although
athlet
allerg
diseas
success
mani
olymp
medal
detriment
contribut
pollut
allergen
environment
factor
occasion
produc
sever
exacerb
allerg
condit
warrant
medic
attent
caus
suboptim
perform
season
exposur
infecti
agent
may
also
induc
season
decrement
athlet
perform
viral
infect
review
nelson
et
al
influenza
reoviru
respiratori
syncyti
viru
manifest
season
peak
winter
earli
caus
signific
morbid
may
trigger
bronchial
hyperreact
may
result
secondari
bacteri
infect
sinu
bronchial
infect
tabl
sever
studi
character
relationship
viral
infect
primarili
thelper
type
respons
enhanc
allerg
diseas
thelper
type
respons
viral
infect
like
influenza
may
trigger
allerg
asthma
interf
toler
aeroallergen
induc
concomit
respons
caus
recruit
cell
lung
peopl
season
allergi
mood
vulner
inflamm
may
interact
peopl
allergi
may
experi
postflu
mood
worsen
without
allergi
often
initi
contact
pollen
airborn
compon
nasal
mucos
eye
studi
shown
allerg
rhinoconjunct
underrecogn
certainli
undertr
elit
athlet
heleniu
et
al
report
result
survey
athlet
compet
summer
event
diagnosi
allerg
rhinoconjunct
common
among
athlet
control
group
nonathlet
p
helbl
et
al
survey
swiss
athlet
particip
sport
respond
questionnair
indic
suffer
hay
fever
report
need
medic
pollen
season
individu
allerg
rhiniti
also
often
increas
bronchial
hyperrespons
allerg
rhiniti
ar
character
nasal
mucosa
edema
result
igemedi
releas
earlyand
latephas
mediat
cytokin
promot
infiltr
mucosa
inflammatori
cell
eosinophil
neutrophil
basophil
cell
macrophag
ar
character
nasal
congest
rhinorrhea
sneez
itch
nose
postnas
drainag
often
associ
allerg
conjunct
manifest
ocular
itch
tear
red
sometim
swell
photophobia
sign
symptom
ar
list
box
allerg
irrit
infecti
hormon
occup
factor
caus
agent
nasal
mucos
edema
peak
present
allerg
rhinoconjunct
occur
year
includ
age
rang
elit
athlet
although
exercis
may
increas
nasal
airway
patenc
like
way
increas
sympathet
nerv
discharg
sever
reason
ar
may
interfer
athlet
perform
rhiniti
often
caus
chang
sleep
pattern
nasal
obstruct
rhinorrhea
sinu
pressur
add
tired
fatigu
impair
athlet
perform
addit
short
burst
sprint
requir
nasal
breath
optim
perform
implic
nasal
obstruct
deleteri
factor
perform
ar
associ
alter
central
nervou
system
cn
function
may
significantli
affect
athlet
abil
perform
use
standard
computerbas
batteri
cognit
process
test
subject
ar
experienc
decrement
reaction
time
attent
vigil
expos
pollen
other
associ
ar
increas
fatigu
depress
anxieti
women
pose
potenti
hindranc
perform
mechan
season
environment
exposur
may
affect
cognit
emot
paramet
elucid
reichenberg
et
al
shown
activ
innat
immun
respons
human
lowdos
endotoxin
exposur
subsequ
releas
proinflammatori
cytokin
eg
tnfa
also
releas
igemedi
respons
nasal
mucosa
see
fig
exposur
endotoxin
secret
cytokin
induc
depress
symptom
anxieti
cognit
impair
absenc
constitut
symptom
eg
decreas
energi
anorexia
drowsi
circul
cytokin
may
also
induc
activ
hpaaxi
elev
corticotrophinreleas
factor
crf
itch
nose
ear
palat
throat
sneez
spell
clear
wateri
rhinorrhea
congest
sinu
headach
mouth
breath
postnas
drip
sleep
disturb
cough
fatigu
cortisol
shown
contribut
major
affect
ill
furthermor
cytokin
respiratori
tract
may
stimul
specif
receptor
present
vagu
nerv
affect
brain
function
pathway
cytokin
releas
could
contribut
decrement
cognit
onset
exacerb
depress
anxieti
thu
detriment
effect
athlet
perform
athlet
must
prepar
variou
climat
condit
encount
train
local
competit
destin
knowledg
temperatur
humid
sunlight
altitud
season
type
concentr
pollen
expos
help
athlet
achiev
peak
perform
use
prophylact
measur
variou
nonpharmacolog
therapi
effect
certain
condit
treatment
ar
salin
nasal
irrig
safe
effect
method
cleans
nasal
mucosa
allergen
improv
nasosinu
diseas
extern
nasal
dilat
use
athlet
increas
nasal
valv
area
narrowest
area
nasal
canal
significantli
decreas
submaxim
exerciseperceiv
exert
heart
rate
ventil
volum
oxygen
use
begin
earliest
olymp
game
athlet
enhanc
athlet
perform
use
foreign
substanc
intern
olymp
commiss
develop
list
prohibit
method
substanc
protect
health
foster
equal
compet
athlet
realm
allerg
diseas
restrict
gener
signific
challeng
exampl
overal
olymp
champion
women
gymnast
olymp
disqualifi
gold
medal
withdrawn
use
medic
ar
contain
pseudoephedrin
allegedli
without
intent
dope
pseudoephedrin
longer
prohibit
list
tabl
winner
men
freestyl
disqualifi
signific
level
ban
drug
ephedrin
detect
postrac
urinalysi
swimmer
use
combin
ephedrinetheophylseason
allergi
athlet
season
allergi
athlet
line
prepar
prerac
treatment
asthma
exampl
highlight
import
athlet
coach
team
physician
understand
potenti
particular
medic
appar
innocu
may
contain
contamin
particular
ban
substanc
establish
univers
intern
standard
olymp
antidop
code
world
antidop
agenc
wada
establish
wada
dissemin
current
inform
substanc
prohibit
use
competit
athlet
wada
maintain
updat
world
antidop
code
prohibit
list
includ
substanc
prohibit
competit
other
alway
prohibit
other
monitor
list
see
tabl
current
updat
inform
regard
antidop
rule
regul
prohibit
substanc
list
found
wwwwadaamaorg
oral
decongest
pseudoephedrin
phenylpropanolamin
effect
reduc
nasal
congest
rhiniti
although
caus
insomnia
loss
appetit
excess
nervous
decongest
longer
prohibit
list
place
monitor
program
detect
pattern
misus
sport
see
tabl
topic
aadrenerg
nasal
decongest
commonli
use
may
caus
rhiniti
medicamentosa
syndrom
rebound
nasal
congest
overus
antihistamin
commonli
use
long
standard
therapi
season
perenni
ar
effect
reliev
symptom
itch
sneez
rhinorrhea
allerg
conjunct
older
firstgener
antihistamin
significantli
limit
sed
anticholinerg
advers
effect
may
compromis
import
psychomotor
skill
eg
reaction
time
visual
discrimin
therefor
avoid
newer
secondgener
antihistamin
prefer
longer
durat
action
minim
cn
advers
effect
intranas
steroid
like
effect
therapi
ar
allerg
conjunct
efficaci
maxim
continu
use
also
proven
asne
benefit
benefit
antihistamin
downregul
numer
step
inflammatori
process
includ
reduc
releas
cytokin
chemokin
use
olymp
athlet
requir
applic
abbrevi
therapeut
use
exempt
tue
sever
studi
shown
concurr
reduct
use
intranas
corticosteroid
bronchial
hyperrespons
leukotrien
modifi
confirm
benefit
allerg
rhiniti
compar
antihistamin
effect
intranas
agent
includ
intranas
antihistamin
ipratropium
bromid
cromolyn
sodium
date
publish
report
immunotherapi
specif
target
elit
athlet
howev
allergen
immunotherapi
significantli
decreas
sever
ar
reduc
requir
pharmacotherapi
improv
qualiti
life
asthma
character
variabl
airflow
obstruct
bronchial
hyperrespons
airway
inflamm
respiratori
viral
infect
common
allergen
irrit
drug
climat
condit
exercis
stimuli
induc
asthmat
exacerb
survey
athlet
repres
olymp
sport
report
experienc
asthma
reason
higher
preval
asthma
among
athlet
exposur
variou
climat
condit
eg
cold
winter
pollen
content
eg
grass
weed
tree
variou
pathophysiolog
chang
occur
exercis
may
promot
bronchial
hyperrespons
strenuou
exercis
result
resist
airflow
phenomenon
call
exerciseinduc
bronchospasm
exerciseinduc
asthma
eia
variou
factor
describ
develop
eia
gener
accept
pathogenesi
eia
involv
loss
heat
water
airway
mucosa
exercis
increas
respiratori
rate
larg
volum
dri
cold
air
reduc
airway
cool
travel
along
tracheobronchi
tree
may
caus
bronchial
constrict
reflex
stimul
airway
receptor
respons
may
lead
chang
mucos
osmolar
promot
mast
cell
degranul
consequ
further
bronchoconstrict
rapid
airway
rewarm
exercis
may
caus
vascular
congest
increas
permeabl
edema
lead
obstruct
eia
symptom
chest
tight
wheez
short
breath
gener
follow
brief
period
bronchodil
occur
initi
exercis
bronchoconstrict
peak
minut
exercis
resolv
minut
refractori
period
hour
recoveri
time
repeat
exercis
caus
less
bronchospasm
observ
although
eia
gener
commenc
follow
cessat
physic
exert
may
also
appear
sustain
activ
track
field
athlet
extens
expos
season
allergen
rate
breath
exce
lmin
shift
nose
breath
combin
mouth
nasal
breath
therebi
increas
deposit
airborn
allergen
inhal
particl
lower
airway
asthmat
subject
allerg
birch
pollen
shown
aggrav
eia
season
allergi
athlet
respons
pollen
season
compar
respons
asthmat
individu
allerg
birch
pollen
report
asthmat
eia
summer
olymp
athlet
screen
perform
experienc
symptom
eia
yet
these
athlet
histori
asthma
howev
report
symptom
asthma
strenuou
exercis
thu
emphas
import
screen
eia
wellcondit
individu
appear
excel
health
eia
common
often
unrecogn
problem
among
schoolag
particip
sport
cohort
adolesc
athlet
diagnos
eia
yet
screen
eia
physic
examin
histori
accur
predict
would
detect
half
children
diagnos
eia
use
spirometri
furthermor
individu
gener
popul
eia
histori
asthma
detail
prior
knowledg
environment
exposur
help
prevent
minim
exacerb
pattern
symptom
establish
prophylaxi
key
therapi
patient
eia
physic
warmup
reduc
eia
continu
lowintens
warmup
effect
interv
warmup
prevent
eia
athlet
certain
cold
condit
experienc
crosscountri
skier
breath
filter
use
although
clear
evid
physic
condit
decreas
eia
improv
pulmonari
function
delay
symptom
eia
reach
threshold
longterm
effect
control
gain
pharmacolog
intervent
common
effect
prophylact
therapi
use
exercis
b
agonist
cromolyn
nedocromil
see
tabl
inhal
corticosteroid
may
help
reduc
bronchial
hyperrespons
use
longterm
antiinflammatori
effect
theophyllin
prepar
anticholinerg
use
tertiari
agent
agent
proven
ineffect
howev
requir
bloodlevel
monitor
narrow
therapeut
window
make
theophyllin
less
desir
altern
agent
athlet
shortact
b
agonist
consid
firstlin
therapi
provid
protect
subject
minim
advers
effect
longact
b
agonist
prevent
bronchial
obstruct
hour
provid
athlet
full
day
protect
formoterol
salbutamol
salmeterol
terbutalin
permit
inhal
complet
abbrevi
tue
b
agonist
includ
dand
lisom
prohibit
competit
accord
prohibit
list
see
tabl
regular
use
b
agonist
without
antiinflammatori
treatment
may
increas
airway
respons
irrit
foster
allergeninduc
late
bronchoconstrict
airway
inflamm
given
central
role
ige
pathogenesi
allerg
diseas
inhibit
ige
respons
use
antiig
antibodi
would
decreas
sensit
effect
mast
cell
basophil
sever
studi
indic
antiig
therapi
effect
treatment
asthma
allerg
rhiniti
howev
implic
athlet
unknown
conclus
evid
support
season
allergi
confer
season
vulner
perform
decrement
competit
train
specif
intervent
prevent
directli
address
allerg
symptomatolog
tailor
athlet
individu
need
specif
circumst
could
prevent
season
decompens
perform
restor
function
baselin
level
